DirectorsTalk Interviews

DirectorsTalk
  • 0.0 (0)
  • INVESTING
  • UPDATED DAILY

DirectorsTalk Interviews focus on financial markets and investment opportunities. The site features interviews with company directors, market analysts, and experts, offering insights into companies' performance, industry trends, and market updates. The content includes Q&A sessions, market commentary, and discussions about business developments, often highlighting the viewpoints of executives from publicly traded companies.

  1. Ilika plc: Stereax Revenues Begin as Goliath Finds New Routes Beyond EVs

    5D AGO

    Ilika plc: Stereax Revenues Begin as Goliath Finds New Routes Beyond EVs

    Ilika Plc (LON:IKA) CEO Graeme Purdy says the company has reached a key commercial inflection point, with Stereax now shipping into medical device supply chains and revenues expected to multiply in the current financial year. He also explains how Goliath remains aligned with EV demand through grant-backed development, while new opportunities in e-bikes and defence applications could broaden the battery platform’s relevance beyond automotive. Key Moments 00:13 — Trading update highlights Stereax’s commercial transition00:36 — Product-related Stereax revenues now recognised01:11 — Commercial-grade electrodes shipped to Cirtec Medical01:27 — Royalties expected as end products reach customers01:39 — Stereax applications across orthodontics and diagnostics02:06 — Smart orthopaedics and implanted sensor opportunities02:36 — Neurostimulation and ophthalmic use cases03:21 — Goliath revenue support through DRIVE35 grants03:50 — Jaguar Land Rover and Oxford steer the roadmap04:24 — Further grant opportunities through DRIVE35 and Horizon Europe04:48 — EV market reset across the US, China and Europe06:00 — Europe posts strong EV growth momentum07:20 — Goliath roadmap expands into new sectors07:37 — Brompton collaboration on safer e-bikes07:49 — UK Defence Agency testing of 10Ah cells08:17 — Annual results due 29 July with Investor Meet Company presentation About Ilika Plc Ilika plc develops solid-state battery technology. Its Stereax batteries are designed for miniature medical and industrial devices, while its Goliath programme targets larger-format cells for electric vehicles and other high-performance applications.

    9 min
  2. DynaResource: Higher Revenues, New Veins And A 2026 Push To Unlock San José de Gracia’s Bigger Prize

    6D AGO

    DynaResource: Higher Revenues, New Veins And A 2026 Push To Unlock San José de Gracia’s Bigger Prize

    DynaResource Inc. (OTCQX: DYNR) President and CEO Rohan Hazelton outlines a stronger financial quarter, with revenue rising to $18 million and adjusted EBITDA reaching $6 million, while explaining how lower grades, new gravity recovery, underground development and fresh exploration targets are shaping the next phase at San José de Gracia. The interview sets up a pivotal second half of 2026, with drilling planned across Tres Amigos, Palos Chinos and Mochimera, VAT recovery expected to ease working capital pressure, and management focused on building towards a larger resource base. Key Moments 00:14 — Q1 revenue jumps to $18m00:53 — Net income hits $2.5m01:02 — Sixth positive EBITDA quarter in a row02:17 — Gravity circuit starts lifting recoveries04:37 — New veins reshape the exploration story05:09 — Victoria vein moves into production07:25 — 4,000m drill programme planned08:37 — Targeting 50,000oz-plus from new drilling09:12 — 2026 focus turns to grades and throughput10:18 — VAT refund decision expected in Q311:16 — Building towards a much larger resource11:47 — Longer-term million-ounce discovery target

    13 min
  3. Manx Financial Group Expands Lending Push with Deposits Up 12% and Discover New Incoming Products

    MAY 19

    Manx Financial Group Expands Lending Push with Deposits Up 12% and Discover New Incoming Products

    Manx Financial Group (LON:MFX) says it is entering a prolonged period of opportunity as economic uncertainty drives demand for short-term lending products, with deposits up 12%, Payment Assist advances rising 29%, and new products including the Fiinu overdraft app nearing launch. Group Chief Executive Officer Douglas Grant also addresses the £1.3 million motor finance provision, explaining why the company believes the issue is now effectively ringfenced while outlining expansion plans in Ireland and premium finance. Key Moments 00:16 – Deposits grow 12% despite difficult lending conditions01:28 – Douglas Grant addresses £1.3 million motor finance provision02:31 – Payment Assist advances jump 29%04:10 – Irish consumer credit licence application submitted04:38 – Fiinu overdraft app launch targeted for summer 202606:12 – Net interest margin rises 14% through short-term lending strategy07:00 – Outlook for 2026-2028 and why uncertainty could benefit the group07:47 – Cross-selling opportunity across 8,000 Payment Assist garages Brief company summary Manx Financial Group is a diversified financial services group providing banking, lending and finance solutions across the Isle of Man and the UK, with operations spanning deposit taking, motor finance, Buy Now Pay Later products, premium finance and business lending.

    9 min
  4. EDX Medical Group: Sir Chris Evans on the Diagnostics Shift That Could Redefine Early Cancer Detection

    MAY 13

    EDX Medical Group: Sir Chris Evans on the Diagnostics Shift That Could Redefine Early Cancer Detection

    Cancer diagnostics are moving beyond broad screening and into precision-led detection, and Sir Chris Evans believes EDX Medical Group (LON:EDX) is positioned at the centre of that transition. In this interview, the founder and Chief Scientific Officer explains why the company is focusing on high-accuracy, clinically validated testing, how partnerships are accelerating commercial traction, and where he sees the biggest gaps in modern healthcare diagnostics. The conversation also touches on scaling revenues, expanding the product pipeline, and why earlier intervention could dramatically change patient outcomes and healthcare costs.Key Moments 00:16 – EDX Medical lands on AIM01:05 – Taking ultra-accurate tests into the home02:14 – Sir Chris Evans’ biotech track record03:21 – The $10bn Verona Pharma win04:18 – The big names backing EDX06:05 – Scotland’s prostate testing push07:16 – 25,000 men, major data set08:23 – Finding cancer before symptoms09:15 – Predicting what MRI will show11:04 – Bowel cancer test launch plans12:18 – Ovarian, lung and breast next13:25 – From R&D to commercial sales14:10 – Why home diagnostics matter14:52 – Evans’ next big biotech bet About EDX Medical GroupEDX Medical Group develops innovative digital diagnostic products and services focused on early disease detection, personalised treatment support, and improving clinical outcomes, with a particular emphasis on cancer and cardiovascular disease diagnostics.

    16 min
  5. Likewise Group plc (LON:LIKE) Navigates Supply Shocks While Accelerating Growth to £300m Ambition

    MAY 6

    Likewise Group plc (LON:LIKE) Navigates Supply Shocks While Accelerating Growth to £300m Ambition

    As geopolitical tensions reshape global supply chains, Likewise Group plc (LON: LIKE) CEO Tony Brewer outlines how deep supplier relationships and strategic investment are keeping the business ahead of the curve. From margin expansion to double-digit sales growth and a clear path towards £300m revenue, this interview reveals how operational discipline and infrastructure scale are driving consistent outperformance in the UK flooring market. Key Moments 00:17 – Managing supply chain risk amid the Iran conflict and raw material inflation01:12 – Why Likewise continues to outperform the UK flooring market01:43 – In-store product strategy across independent retailers02:34 – Digital tools driving efficiency and customer access03:33 – Logistics expansion and capacity for £300m revenue04:30 – Financial performance: profit up 56%, margins improving05:14 – Strong start to the year with 15% sales growth05:32 – Outlook supported by scale, teams and supplier strength

    7 min
  6. Volta Finance: Structural Strengths Shield Against Market Stress

    APR 21

    Volta Finance: Structural Strengths Shield Against Market Stress

    Volta Finance’s (LON:VTA) resilience is being tested against a backdrop of geopolitical shocks and AI-driven disruption, but the underlying story is far more robust than the market suggests. In this interview, Mark Thomas of Hardman & Co breaks down why structural protections within CLOs and disciplined portfolio management continue to underpin performance, even as sentiment drives volatility and discounts widen. At the heart of the discussion is a clear tension: falling loan prices and macro uncertainty versus a portfolio engineered to absorb shocks. Thomas explains how embedded safeguards in CLO structures, combined with Volta Finance’s manager selection and active oversight, have historically delivered resilience, while also warning investors to expect short-term swings in NAV and share price as sentiment ebbs and flows. Key Moments 00:04 – Volta in Focus00:15 – Why the Disclaimer Is There00:49 – What’s Driving the Note01:23 – Why Volta Looks More Resilient01:58 – The Double Discount Risk02:38 – CLO Defaults Stay Low03:29 – Lower Risk by Design04:01 – Evidence of Manager Edge05:06 – Why Exposure Was Kept Low05:40 – The Main Risks for Investors

    7 min
  7. Cora Gold Locks in $120M Funding Milestone as Bert Monro Targets Fast-Track to First Gold

    APR 20

    Cora Gold Locks in $120M Funding Milestone as Bert Monro Targets Fast-Track to First Gold

    Cora Gold Ltd (LON:CORA) has secured a transformative $120 million funding package, putting it on a clear path to production and removing a major layer of uncertainty. In this conversation, Bert Monro explains how a strategic streaming deal with Eagle Eye not only fully funds the project but could accelerate construction timelines and preserve shareholder value in ways traditional financing might not.Key Moments 00:22 $120M funding secured01:06 Streaming model explained02:05 Financing comparison vs traditional debt03:34 Plan to replace 50% with debt04:09 Strong project economics outlined05:02 Eagle Eye strategic role06:14 Timeline to production

    8 min
  8. Time Finance: How SMEs Can Strengthen Cash Flow and Thrive Through Uncertainty

    APR 17

    Time Finance: How SMEs Can Strengthen Cash Flow and Thrive Through Uncertainty

    Ed Rimmer CEO of Time Finance (LON:TIME) lays out why planning alone is no longer enough for SMEs navigating rising costs and global disruption. He highlights the growing gap between profitability and survival, and explains why access to flexible funding, not just traditional lending, is becoming the decisive factor in whether businesses can ride out volatility and seize opportunity.🎯 Key Moments 00:12 – Why forecasting matters more in uncertain markets00:20 – The real-world pressures hitting SMEs: inflation, delays, fuel costs01:44 – Pricing strategy dilemmas in volatile conditions02:02 – “Cash is king” and why profit doesn’t guarantee survival02:31 – Funding options beyond traditional loans and overdrafts03:12 – How asset-based lending unlocks flexible growth capital04:06 – Why brokers are critical in navigating complex funding markets What Time Finance does: Time Finance provides flexible funding solutions to SMEs, including asset-based lending such as invoice finance and asset finance, helping businesses improve cash flow and support growth. https://www.directorstalkinterviews.com/time-finance-how-smes-can-strengthen-cash-flow-and-thrive-through-uncertainty-video/4121249214

    6 min
See All (172)

About

DirectorsTalk Interviews focus on financial markets and investment opportunities. The site features interviews with company directors, market analysts, and experts, offering insights into companies' performance, industry trends, and market updates. The content includes Q&A sessions, market commentary, and discussions about business developments, often highlighting the viewpoints of executives from publicly traded companies.

Information

  • Creator
    DirectorsTalk
  • Years Active
    2020 - 2026
  • Episodes
    172
  • Rating
    Clean
  • Copyright
    © DirectorsTalk
  • Show Website
    DirectorsTalk Interviews